A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CAR / cancer-associated retinopathy

[Related PubMed/MEDLINE]
Total Number of Papers: 123
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CAR  (>> Co-occurring Abbreviation)
Long Form:   cancer-associated retinopathy
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy. aAbs
2019 A case of cancer-associated retinopathy with chorioretinitis and optic neuritis associated with occult small cell lung cancer. SCLC
2019 Cancer-Associated Retinopathy and Treatment with Intravenous Immunoglobulin Therapy. A Seldom Used Approach? IGIV
2019 Cancer-associated retinopathy in ampullary pancreatic cancer. ---
2019 Cancer-associated Retinopathy with Neuroendocrine Combined Large-cell Lung Carcinoma and Adenocarcinoma. LCNEC, SCLC
2019 Case Series of Cancer-associated Retinopathy (CAR). ---
2019 [Cancer-associated retinopathy (CAR) in neuroendocrine carcinoma of the uterus]. BCVA, SD-OCT
2018 Are Anti-Retinal Autoantibodies a Cause or a Consequence of Retinal Degeneration in Autoimmune Retinopathies? aAbs, AR
2018 Cancer-associated retinopathy after surgery for breast cancer: a case report and review of the literature. ---
10  2018 Cancer-associated retinopathy preceding the diagnosis of cancer. ---
11  2018 InVivo Adaptive Optics Ophthalmoscopy Correlated with Histopathologic Results in Cancer-Associated Retinopathy. AOSLO
12  2018 Paraneoplastic syndromes in ophthalmology. MAR, PCD
13  2017 Impact of Autoantibodies against Glycolytic Enzymes on Pathogenicity of Autoimmune Retinopathy and Other Autoimmune Disorders. aAbs
14  2017 Unilateral cancer-associated retinopathy: diagnosis, serology and treatment. ERG
15  2016 Cancer-associated retinopathy as the leading symptom in colon cancer. ---
16  2016 GCAP1, Rab6, and HSP27: Novel Autoantibody Targets in Cancer-Associated Retinopathy and Autoimmune Retinopathy. aAbs, AR, GCAPs, HSP27, Rab6A
17  2016 Paraneoplastic retinopathy associated with occult bladder cancer. ERG, PET-CT
18  2016 Unique epitopes for carbonic anhydrase II autoantibodies related to autoimmune retinopathy and cancer-associated retinopathy. anti-CA II, AR
19  2015 A Man with Paraneoplastic Retinopathy plus Small Fiber Polyneuropathy Associated with Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma): Insights into Mechanisms. ERG, PLEX, SFPN, WM
20  2015 Large cell neuroendocrine carcinoma of the lung with cancer-associated retinopathy. LCNEC, SCLC
21  2015 Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer. aAbs
22  2015 Retinal imaging with en face and cross-sectional optical coherence tomography delineates outer retinal changes in cancer-associated retinopathy secondary to Merkel cell carcinoma. FD-OCT, GVF, PR
23  2015 Spontaneous regression of small cell lung cancer combined with cancer associated retinopathy. CTL, SCLC, SR
24  2014 Autoimmune retinopathy associated with carcinoid tumour of the small bowel. ---
25  2014 Cystoid macular edema from cancer-associated retinopathy. CME
26  2014 Small cell lung cancer and progressive retinopathy. CRMP
27  2013 Cancer associated retinopathy with periphlebitis and bilateral vitreous hemorrhage. ---
28  2013 Detection of autoantibodies against heat shock proteins and collapsin response mediator proteins in autoimmune retinopathy. 2-DE, AAbs, AR, HSPs
29  2013 Significance of Anti-retinal Autoantibodies in Cancer-associated Retinopathy with Gynecological Cancers. aAbs
30  2013 Treatment of cancer-associated retinopathy with rituximab. ---
31  2013 [Clinical characteristics of paraneoplastic retinopathy and optic neuropathy]. BDUMP, PNS, PON, PRON
32  2013 [Ocular paraneoplastic syndrome: cancer-associated retinopathy]. ERG
33  2012 Autoantibodies against the Ca(2+)-binding protein recoverin in blood sera of patients with various oncological diseases. AAR
34  2012 Autoimmune retinopathy. MAR, npAIR
35  2012 Bilateral paraneoplastic optic neuropathy and unilateral retinal compromise in association with prostate cancer: a differential diagnostic challenge in a patient with unexplained visual loss. autoAbs, CAON, CRAO, ERGs, GVFs, IVFA, OCT, PVEPs
36  2012 Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy. ---
37  2012 [Paraneoplastic retinopathy]. MAR, PR
38  2011 Cancer-associated retinopathy: update on pathogenesis and therapy. CTLA-4, VEGF
39  2011 Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction. MAR, PR, TRPM1
40  2011 [A case of cancer-associated retinopathy rapidly leading to blindness with a unique pupillary light reflex]. ---
41  2010 Cancer-associated retinopathy in neuroendocrine carcinoma of the fallopian tube. ---
42  2010 Cancer-associated retinopathy with retinal periphlebitis in a patient with ovarian cancer. ERG
43  2010 Cancer-associated retinopathy: a new mechanistic insight on vascular remodeling. ---
44  2010 Choroidal neovascularization associated with cancer-associated retinopathy. CNV, IRBP, PDT
45  2010 Clinicopathological roles of aberrantly expressed recoverin in malignant tumor cells. ---
46  2010 [Paraneoplastic retinopathy and optic neuropathy]. ERG, MAR, PON, SCLC
47  2009 Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. MAR, PR
48  2009 Management of autoimmune retinopathies with immunosuppression. AIR, npAIR
49  2008 Antibodies to 46-kDa retinal antigen in a patient with breast carcinoma and cancer-associated retinopathy. ---
50  2008 Autoimmune retinopathy: a review and summary. AIR, AZOOR, ERGs, MAR, MEWDS, npAIR
51  2008 Cancer-associated retinopathy (CAR) with electronegative ERG: a case report. MAR
52  2008 [Case of cancer-associated retinopathy in which immediate treatment succeeded]. CT
53  2008 [New drug therapy for retinal degeneration]. ERG, PDE, RD, RP, RPE
54  2007 Cancer-associated retinopathy in patients with breast carcinoma. RAs
55  2007 Establishment of a novel small cell lung carcinoma cell line with specific recoverin expression from a patient with cancer-associated retinopathy. ---
56  2007 Long-term survival of a patient with small cell lung cancer associated with cancer-associated retinopathy. SCLC
57  2007 Paraneoplastic neurological syndromes. CGP, EM, LE, LEMS, MAR, OM, PNS, SPS, SSN
58  2007 [Cancer associated retinopathy (CAR). Two clinical cases and review of the literature]. MAR
59  2006 Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome. ---
60  2006 Cone dysfunction as a paraneoplastic syndrome associated with retinal antigens approximating 40 kiloDalton. ---
61  2006 Effects of cytotoxic T lymphocyte antigen 4 (CTLA4) signaling and locally applied steroid on retinal dysfunction by recoverin, cancer-associated retinopathy antigen. CTLA-4, CTLs, ERG, ONL, PBS
62  2005 Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung. ---
63  2005 Bilateral diffuse uveal melanocytic proliferation in a patient with cancer-associated retinopathy. BDUMP, Hsc70
64  2004 Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. AR, ERG, PR
65  2004 Cancer-related diseases of the eye: the role of calcium and calcium-binding proteins. ---
66  2004 Cellular targets of anti-alpha-enolase autoantibodies of patients with autoimmune retinopathy. ---
67  2004 Clinical and immunologic aspects of cancer-associated retinopathy. Hsc70
68  2004 Clinicopathological features of gastric cancer cases and aberrantly expressed recoverin. ---
69  2003 Aberrantly expressed recoverin is functionally associated with G-protein-coupled receptor kinases in cancer cell lines. GRKs, Rec
70  2003 Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy. NSCLC
71  2003 Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy. ---
72  2003 Invasive thymoma with paraneoplastic retinopathy. ---
73  2002 Antirecoverin antibody in the aqueous humor of a patient with cancer-associated retinopathy. ---
74  2002 Autoantibodies to photoreceptor membrane proteins and outer plexiform layer in patients with cancer-associated retinopathy. ---
75  2002 Cancer-associated retinopathy associated with invasive thymoma. ---
76  2002 Frequent detection of anti-recoverin cytotoxic T-lymphocyte precursors in peripheral blood of cancer patients by using an HLA-A24-recoverin tetramer. CTL, CTLp, PBMC
77  2002 Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway. ---
78  2002 Pathological roles of recoverin in cancer-associated retinopathy. ---
79  2002 Vaccination with recoverin, a cancer-associated retinopathy antigen, induces autoimmune retinal dysfunction and tumor cell regression in mice. ERG, Rec
80  2002 [Ocular manifestations of cancer]. BDUMP, MAR
81  2001 Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome. CTL
82  2001 In vitro inhibition of antirecoverin immunoglobulin-mediated death of mammalian photoreceptor cells. DAPI, TUNEL
83  2001 Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision. PNA, PNS, SCLC
84  2001 Mechanisms of photoreceptor cell death in cancer-associated retinopathy. ERG, HSC, ROS
85  2001 Molecular cloning and characterization of human PTB-like protein: a possible retinal autoantigen of cancer-associated retinopathy. PTB, PTBLP, RRMs
86  2001 Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation. ERG
87  2001 Tamoxifen side effects, age-related macular degeneration (AMD) or cancer associated retinopathy (CAR)? AMD, flash-ERG
88  2000 Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines. Hsc70
89  2000 Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration. ELISA, RP
90  2000 Molecular cloning and characterization of a new neuron-specific homologue of rat polypyrimidine tract binding protein. PTB, PTBLP, RRMs
91  2000 Tubby-like protein 1 as an autoantigen in cancer-associated retinopathy. TULP1
92  2000 [Carcinoma-associated retinopathy: a review with clinical examples]. ERG
93  1999 Anti-recoverin antibodies cause the apoptotic death of mammalian photoreceptor cells in vitro. ---
94  1999 Cancer-associated retinopathy during treatment for small-cell lung carcinoma. ---
95  1999 Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo. ERG, Hsc70, INL, ONL
96  1999 Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy. ERG, MAR
97  1999 Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy. Hsc70, HSP
98  1999 Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. ---
99  1999 Unique retina cell phenotypes revealed by immunological analysis of recoverin expression in rat retina cells. ---
100  1998 Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. TUNEL